An ex vivo native environment precision medicine AML test and the correlation with responses to 1st line treatment.

Juan Ballesteros,Pau Montesinos,David Martínez Cuadrón,Joaquín Martínez,Josefina Serrano,Jaime Pérez de Oteyza,Pascual Fernández,Gabriela Rodriguez-Macias,Maria Belen Vidriales,Pilar Herrera,Mar Tormo,Juan Bergua,Raimundo García-Boyero,Susana Vives,María Ángeles Fernández,Jesús Villoria,Federico Moscardó,Iñaki F. Trocóniz,Miguel A. Sanz

An ex vivo native environment precision medicine AML test and the correlation with responses to 1st line treatment.

2016

Juan Ballesteros
Pau Montesinos
David Martínez Cuadrón
Joaquín Martínez
Josefina Serrano
Jaime Pérez de Oteyza
Pascual Fernández
Gabriela Rodriguez-Macias
Maria Belen Vidriales
Pilar Herrera
Mar Tormo
Juan Bergua
Raimundo García-Boyero
Susana Vives
María Ángeles Fernández
Jesús Villoria
Federico Moscardó
Iñaki F. Trocóniz
Miguel A. Sanz

e18510Background: The aim of this study is to determine the ability of Vivia's novel test (based on studying the ex-vivo sensitivity to drugs) to predict the complete remission (CR) rates after ind...

Keywords:

Precision medicine
Ex vivo
Pathology
Medicine
Oncology
Correlation
complete remission
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations